chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for Covid 19 on May 26, 2022.  Had mild/moderate symptoms including sore throat, fever, congestion and cough.  Was prescribed and took Paxlovid for 5 days.  Visited urgent care after 3 weeks due to lingering cough and chest tightness.  Chest x-rays taken and indicated no pneumonia.  Was prescribed an albuterol inhaler.
Patient was given Pfizer as a second dose on 11/22/21. First dose of Moderna, received outside of the facility, was done on 4/27/21. Patient did not refuse or explain to nurse that he received Moderna as a first vaccine. Per nurse, the first dose of Moderna wasn't documented in database. Patient was monitored after administration. No adverse reaction noted.
Shot taken 9:30AM 2/25/21  DaQuil taken around 3:30PM  Chills,  violent  shakes.  Around 6:00PM 911 called , EMT arrived I did not know birthdate,  where I lived,  date, or where I was.  Transported to ER  do not remember any part of the trip or arriving at the ER.   Bright red circle around shot with fever still have 3/4/21 plus sore.
Pt recv vax on 6/18/98; on same day pt exp unconsolable crying & seizure-like activity.  Pt imp on 8/20/98.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In January 2012, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not function as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 11-JUL-2016, the patient was treated by a physician at a primary care office for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Right eye twitching; Eyes were watery; left eye had conjunctivitis like symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 09:00 (Lot number: EN6208) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hashimotos" (unspecified if ongoing), notes: Hashimotos, I have had autoimmune reactions affect my eyes for the past few years; "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID. Past drug history included: Percocet, reaction(s): "known allergies: Percocet", notes: known allergies: Percocet; Zyrtec, reaction(s): "known allergies: Zyrtec", notes: known allergies: Zyrtec; Augmentin, reaction(s): "known allergies: Augmentin", notes: known allergies: Augmentin. The following information was reported: BLEPHAROSPASM (non-serious) with onset 29Mar2021 12:00, outcome "recovering", described as "Right eye twitching"; LACRIMATION INCREASED (non-serious) with onset 29Mar2021 12:00, outcome "recovering", described as "Eyes were watery"; CONJUNCTIVITIS (non-serious) with onset 29Mar2021 12:00, outcome "recovering", described as "left eye had conjunctivitis like symptoms". Therapeutic measures were not taken as a result of blepharospasm, lacrimation increased, conjunctivitis. Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient didn't have this onset of symptoms before getting the vaccine. The patient had autoimmune reactions affecting eyes for the past few years, so this may be similar response to a foreign substance. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Moderna COVID-19 Vaccine EUA  A few days after the vaccine an odd large (4" diameter) somewhat circular bruise type mark appeared around the vaccination cite.  No soreness, just the odd mark.
Information has been received concerning a vaccinee who experienced a sore arm and swelling in the arm and didn't feel well all night. Unspecified medical attention was sought.
Burning in heart-chest area; Bitter taste in mouth; Chills; Nausea; Fever; feeling under the weather; bit of sore throat; feels warm; little bit of a headache; little dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little dizzy), MALAISE (feeling under the weather), OROPHARYNGEAL PAIN (bit of sore throat), FEELING HOT (feels warm) and DYSPEPSIA (Burning in heart-chest area) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy and Bipolar disorder since 1993. Concomitant products included VALPROATE SEMISODIUM (DEPAKOTE), FLUPHENAZINE DECANOATE (PROLIXIN [FLUPHENAZINE DECANOATE]) and BENZATROPINE MESILATE (COGENTIN) for Bipolar disorder, VITAMIN D3 for an unknown indication.   On 15-Mar-2021 at 9:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021 at 9:15 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced DIZZINESS (little dizzy) and HEADACHE (little bit of a headache). On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (feeling under the weather), OROPHARYNGEAL PAIN (bit of sore throat) and FEELING HOT (feels warm). On an unknown date, the patient experienced DYSPEPSIA (Burning in heart-chest area), DYSGEUSIA (Bitter taste in mouth), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Fever). The patient was treated with FAMOTIDINE (PEPCID AC) at a dose of 1 dosage form; OMEPRAZOLE at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 16-Mar-2021, DIZZINESS (little dizzy) and HEADACHE (little bit of a headache) had resolved. At the time of the report, MALAISE (feeling under the weather), OROPHARYNGEAL PAIN (bit of sore throat) and FEELING HOT (feels warm) outcome was unknown, DYSPEPSIA (Burning in heart-chest area) was resolving, DYSGEUSIA (Bitter taste in mouth) and CHILLS (Chills) had not resolved and NAUSEA (Nausea) and PYREXIA (Fever) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received on 10 May 2021 and contains updated Vaccine information, patient demographics, medical history, concomitant medication, treatment drugs, new events, and outcome of the events
Hot flashes/fever, chills, headaches, body aches, left arm tenseless, hand swelling on left side, nausea, dizzy
received 1st dose of Shingrix in June 18th 2018; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 18 June 2018, batch number HG4P3, expiry date 13th July 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of vaccination the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up . This case was linked with case US2021172401, reported by same reporter for different patient.
MA gave patient expired vaccine.  Provider was notified after this had been done. The patient was notified. The patient did not have any reaction after vaccine was given.
she reports 2-3 days after receipt developed a severely pruritic erythematous macular, papular  dermatitis to her neck and chin. Lesions have continued to erupt and subsequently developed to upper chest, arms, especially right arm and flexor surfaces and a small area to her left flank. Her face, eyes are pruritis, and especially chin. It has disrupted sleep. She has self treated with CBD oil, aloe Vera gel, and tea tree oil which has been most helpful. She took zyrtec 1 dose last night and was able to sleep. She reports one episode of diarrhea after vaccine receipt, but none further. She had chills, myalgias and fatigue days 1-2 post receipt but then resolved. She denies fever, chills, headache, dyspnea, edema, cough, CP, nausea, emesis  She denies new soaps, personal care products, detergents etc.  Patient denies any other known adverse events following immunizations.
Linear blisters dev approx 1 inch to left of injection site R thigh-resolving rapidly.
Prev. healthy 4 mo. old admitted to ER status epilepticus and intubated upon arrival. During hosp. had poss. aspiration pneumonia (+) culture Moroxella catarrhalis, treated x 7 days with Cefitime. Had EEG x3, LP x3, MRI head, echocardiogram.   6/1/09 Hospital records received DOS 4/13/09 to 4/20/09. FINAL DIAGNOSIS: 'Probable neonatal seizures' Encephalopathy secondary to unknown etiology. Post vaccination: Admitted in status epilepticus. Not breathing. Vomited. Disconjugate gaze. Aspiration pneumonia. Left corneal epithelial defect secondary to lagophthalmos. Recommended genetics and neurology follow up.  6/17/09 ICD-9 codes received. 78039 Convulsions, 5070 Pneumonitis due to inhaltion of food or vomitus, 51881 Acute respiratory failure, 34830 Encephlalopathy unspecified, 2762 Acidosis, 9181 Superficial injury of cornea, 37420 Lagophthalmos, 26650 Volume depletion unspecified.\
Information has been received from a health professional for the Pregnancy Registry for GARDASIL, concerning a 18 year old female with no pertinent medical history and no previous pregnancies who on 24-FEB-2010 was vaccinated with a first dose of GARDASIL (route and lot# not reported). The patient's last menstrual period (LMP) was 10-JAN-2010 and her expected date of delivery was 14-OCT-2010. On 04-MAR-2010 to 11-MAR-2010, the patient was treated with metronidazole for bacterial vaginitis. On 12-MAR-2010, 8 weeks from LMP, the patient had an elective termination. At the time of the report, the patient's outcome was unknown. Upon internal review, elective termination was determined to be an other important medical event. Additional information has been requested.
Pt. experienced difficulty breathing, hives, red swollen bumps over entire body, severe itching, loss of appetite for a 2-1/2 weeks duration.  Permanent scar where injection was given.
Was given Moderna vaccine on 4/24/2021 and inadvertently given Pfizer/BioNTech for second dose on 5/22/2021
she had blisters in her mouth and around her mouth; her eyes were swollen; This is a spontaneous report from a contactable Pharmacist. A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: unknown) via an unspecified route of administration on an unspecified date (age at vaccination 35-year-old) as dose 1, single for covid-19 immunization. The patients medical history and concomitant medications were not reported. One day after vaccination patient experienced blisters in her mouth and around her mouth and her eyes were swollen. Treatment included for adverse event eye swelling was steroid drops. The outcome of event was recovered on an unspecified date.  Information about lot/batch number has been requested.
Patient became very fussy, got a runny nose and what appeared to be cold-like symptoms. I checked her neck and her lymph nodes, with the one on her left being larger, were swollen to the size of grapes. The node on the right has since decreased a good bit: however, the node on the left is still quite hard and much larger than it should be over 2 months later.
Information has been received from a consumer concerning her daughter with no known drug allergies who was vaccinated with a dose of MMR II (dose, route and lot# not reported) as a young child. The patient had a severe reaction with parotitis and was hospitalized for 2 weeks. The patient's outcome was unknown. The patient subsequently experienced throat closing, could not breathe, chest pain, chills, burning of throat, chest "like severe reflex", pain in left elbow joint and left side of neck, stabbing pain in leg, visual issues "like letters moving around", panic attack, feeling of "everything got small around her", stabbing knife pain in back, stabbing knife pain in ribs and side, cramping of stomach and severe back pain while on therapy with RECOMBIVAX HB (WAES# 0908USA03760). Additional information has been requested.
Fever 100 degrees, severe pain in the right shoulder, all body muscle pain, stomach pain, nausea, severe headache, pain in joints and bones, rapid heartbeat, sleeplessness, extreme body weakness next day.
Injection site - swollen, red, soreness, fever (at the injection site) left leg where DTAP + Polio were given.
This spontaneous report was received from a physician via a company representative, referring to a 12 year old female patient. No information about the patient´s medical history, concurrent conditions or concomitant medications was provided. On an unspecified date in 2012 (reported as "about 5 years ago"), the patient was vaccinated with a dose of GARDASIL, intramuscular, (dose, lot # and expiration date were not provided) for prevention of human papillomavirus. On an unknown date in 2012 (reported as "about 5 years ago"), after receiving a dose of GARDASIL (dose number unspecified), the patient "passed out"  (loss of consciousness). It was also reported that the patient sought medical attention, but no intervention to prevent serious criteria was performed. No product quality complaint (PQC) was involved. It was reported that, on an unknown date, the patient recovered from loss of consciousness. Additionally, it was reported that the patient finished the series of GARDASIL. The causal relationship between GARDASIL and loss of consciousness was not provided. Upon internal review, the event loss of consciousness was determined to be medically significant.
Pt exp positional vertigo on the rt approx 12 hrs p/receiving Influenza vax; Pt vision blanked out for two seconds;
Left arm red and hot by night after shot. Today arm is still red, but half of arm is hot around the shoulder. Pain when he moves but is not really bad.
Had Covid 19 Pfizer Bivalent vaccine number 4 on  Friday 1/62023  at 11:55AM. On Saturday 1/7/2023 at 8:00PM I developed headache and body aches with a 102 degree fever. I took some Advil and went to bed. On Sunday morning I still had fever of 102  as well as headache and body aches and continued with Advil. On Monday morning 1/9/2023 I now had pain in my stomach area and chest area, fever was still 102 degrees and I continued with Advil. I spike a fever of 105 and husband to me to hospital where after many tests they found 2 pulmonary embolism's in my right lung.
Patient reports a pressure behind his eyes bilaterally. No further complaints. Reports this feels similar to a symptom he had when he had COVID previously.
injection site feels hot; injection site is getting really swollen and red and feels hot; injection site is getting really red and feels hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site feels hot), VACCINATION SITE SWELLING (injection site is getting really swollen and red and feels hot) and VACCINATION SITE ERYTHEMA (injection site is getting really red and feels hot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE WARMTH (injection site feels hot), VACCINATION SITE SWELLING (injection site is getting really swollen and red and feels hot) and VACCINATION SITE ERYTHEMA (injection site is getting really red and feels hot). At the time of the report, VACCINATION SITE WARMTH (injection site feels hot), VACCINATION SITE SWELLING (injection site is getting really swollen and red and feels hot) and VACCINATION SITE ERYTHEMA (injection site is getting really red and feels hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information was provided.
Extreme effects on the nervous system. Very bad muscular pain, loss of sleep, low grade fever which peaked 3 days after injection but started almost immediately. Affects were not clear till day 8.
~01:15PM PATIENT RECEIVED IM VACCINE IN LEFT DELTOID WHILE SEATED. ADMINISTERED BY PHARMACY INTERN, PATIENT REPORTED NO ISSUES. "FEELING FINE, I'M OK" ~01:17PM AFTER RECEIVING VACCINE CARD AND BEING REQUESTED TO WAIT THE 15 MINUTES FOR OBSERVATION, PATIENT STATED THAT HE HAD NEVER FAINTED AFTER A SHOT, ONLY AFTER BLOODRAWS, BUT WAS ADVISED TO REMAIN SEATED JUST IN CASE. IMMEDIATELY AFTER HE STATED HE FELT LIGHT HEADED AND THEN PROCEEDED TO SLUMP IN AN ADJACENT CHAIR. PATIENT WAS UNRESPONSIVE TO INQUIRIES, BUT SNORING WAS AUDIBLE.  ~01:17PM PATIENT WAS LOWERED TO THE FLOOR INTO A SUPINE POSITION WHILE NECK WAS SUPPORTED DURING THE MOVEMENT PROCESS, AND EMTS WERE NOTIFIED BY PHARMACY STAFF VIA 911.  ~01:18PM PATIENT REGAINED CONSCIOUSNESS AFTER ABOUT ~10-20 SECONDS TOTAL, OPENED HIS EYES, AND WAS SPEAKING TO HIS WIFE AND STAFF. PATIENT WAS ADVISED TO REMAIN IN POSITION UNTIL EMTS ARRIVED TO ASSESS THE PATIENT ~01:21PM EMTS ARRIVED ON SITE TO ASSESS SITUATION, VITALS WERE CONSIDERED NORMAL AND PATIENT REFUSED AMBULANCE TO HOSPITAL.  ~01:30 EMTS LEFT SCENE, PATIENT REPORTED FEELING NORMAL AND WOULD BE ASSISTED BY WIFE, LEFT THE SCENE WALKING NORMALLY  BELIEVED TO BE A VAGAL RESPONSE FOLLOWING THE IMMUNIZATION
Pt was given vaccine from a bottle that was in the refrigerator on day 31. Moderna was notified and they returned information stating the the vaccine should be fine and it should still be effective, but patient may get another if they feel it is necessary, attempted to call Pt left Voice messages on his phone will information and call back #'s
Blindness: A pharmacist reported that a pt received vax and subsequently developed blindness. No further information is available at the date of this report.
Client reports had Erythema and associated pustules appear about a week after injection on upper arm distal to the vaccine site.  It has now migrated to the underside of the arm above the elbow and appears like a large bite mark with a few pustules inside the bite erythema that had been scratched.
6 x 7 cm indurated red patch of prox. lateral (L) upper arm and no significant tenderness and no fluctuance or warmth.
Seven minutes after the patient received the Pfizer Dose 1 COVID-19 vaccination, patient started to feel nervous and hot. While waiting to receive some water she started complaining of being dizzy and wanted to lie down.  The pharmacist escorted her to the immunization area and the patient became weak and started loosing her balance.   She was put in a sitting position on the floor with her legs out.   She then went into a blank stare to the ground, her hands flexed to her side, and wet herself.  She became alert  within seconds and was talking and acting normally.  We called EMS and they transferred her to an emergency room for evaluation.
Zostavax vaccination given intramuscularly instead of subcutaneous.  Patient reported no problems.
Patient reports sore arm lasting  more than 3 weeks after getting vaccine. States especially sore and painful when raising left arm above neck. Reports it has gotten better but may follow up  with MD if pain continues.
Accidentally given a Pfizer vaccine instead of Shingrix. Patient has already received both doses of Moderna in December and January.
fever; slept a lot the next day; A spontaneous report was received from a reporter (consumer )  concerning an unknown year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced slight reaction to the vaccine, fever and slept a lot next day.  The patient's medical history was not provided. The relevant concomitant medications were also not provided.  On Jan-2021 , prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) through unknown route of administration  for prophylaxis of COVID-19 infection.   On Jan-2021, the patient experienced  slight reaction to the vaccine, fever and slept a lot next day.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   the outcome of the event was unknown .
hives & severe itching approx 32 hrs p/vax-legs, arms, neck & face; treated w/po & topical DPH, Duricef; all w/no relief;
This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with a improperly stored doses of RECOMBIVAX HB (lot# not reported). This is one of several reports received from the same source. Additional information has been requested.